Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial

Article Abstract:

Long-term rifampin therapy for three to six months may be effective in treating staphylococcal infections around orthopedic implants. Traditionally, these infections are hard to treat and often the implant must be removed. Researchers evaluated long-term rifampin and ciprofloxacin compared to ciprofloxacin and placebo in 33 patients with staphylococcal infection around their implant. Of the 24 who completed the study, cure rates were 100% in the rifampin-ciprofloxacin group and 58% in the placebo-ciprofloxacin group. Five patients who dropped out were also successfully treated with rifampin.

Author: Widmer, Andreas F., Zimmerli, Werner, Blatter, Marianne, Frei, R., Ochsner, Peter E.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1998
Evaluation, Complications and side effects, Staphylococcal infections, Rifampin, Orthopedic implants

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


A 24-Year-Old Woman With Anorexia Nervosa

Article Abstract:

Anorexia nervosa may be associated with significant medical and psychological dysfunction. Patients with the eating disorder fall below 85% of the lowest normal weight for their height and age, are fearful of gaining weight, and often have a disordered body image. There may be genetic, physiologic, behavioral, and family factors related to anorexia. Treatment often includes psychotherapy, antidepressant medication, and systematic dietary modification. A 24-year-old woman with a seven-year history of the eating disorder describes her condition, and physicians discuss it.

Author: Halmi, Katherine A.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1998
Care and treatment, Case studies, Eating disorders

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Fluoxetine after weight restoration in anorexia nervosa: A randomized controlled trial

Article Abstract:

A test was conducted to determine whether antidepressant fluoxetine could promote recovery and prolong time-to-relapse among patients with anorexia nervosa following weight restoration. The study failed to demonstrate any benefit from fluoxetine in the treatment of patients with anorexia nervosa following weight restoration.

Author: Walsh, B. Timothy, Kaplan, Allan S., Carter, Jacqueline C., Pike, Kathleen M., Rockert, Wendi, Attia, Evelyn, Olmsted, Marion, Devllin, Michael J., Woodside, Blake, Roberto, Christina A., Parides, Michael
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2006
United States, Dosage and administration, Antidepressants, Fluoxetine, Clinical report

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Drug therapy, Anorexia nervosa
Similar abstracts:
  • Abstracts: Oral cobalamin for treatment of pernicious anemia? A Structured Teaching and Self-management Program for Patients Receiving Oral Anticoagulation: A Randomized Controlled Trial
  • Abstracts: Treatment of Irritable Bowel Syndrome With Chinese Herbal Medicine: A Randomized Controlled Trial. Irritable bowel syndrome
  • Abstracts: Maintenance of certification and the outside world. The Southwestern Surgical Congress: a seal of approval. 2005 ADA annual session concurrent meetings
  • Abstracts: Prevalence and impact of cyclic mastalgia in a United States clinic-based sample. European randomized, multicenter study of goserelin (Zoladex) in the management of mastalgia
  • Abstracts: Predictors of low CD4 count in resource-limited settings. Predictors of mortality for patients with advanced disease in an HIV palliative care program
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.